Will DigitalOcean Stock Bounce Back?
DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…
Sell
50
IRTC Quote, Financials, Valuation and Earnings
Last price:
$142.93
Seasonality move
:
6.56%
Day range:
$139.07 - $144.25
52-week range:
$55.92 - $144.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.23x
P/B ratio:
52.56x
Volume:
347K
Avg. volume:
536.1K
1-year change:
62.07%
Market cap:
$4.6B
Revenue:
$591.8M
EPS (TTM):
-$3.14
Analysts' Opinion
-
Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $140.42, iRhythm Technologies has an estimated downside of -1.59% from its current price of $142.69.
-
Price Target UpsideAccording to analysts, the highest upside price target is $167.00 representing 17.04% upside increase from its current price of $142.69.
Fair Value
-
According to the consensus of 10 analysts, iRhythm Technologies has -1.59% downside to fair value with a price target of $140.42 per share.
IRTC vs. S&P 500
-
Over the past 5 trading days, iRhythm Technologies has overperformed the S&P 500 by 3.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
iRhythm Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
iRhythm Technologies has grown year-over-year revenues for 19 quarters straight. In the most recent quarter iRhythm Technologies reported revenues of $158.7M.
Earnings Growth
-
iRhythm Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter iRhythm Technologies reported earnings per share of -$0.97.
Enterprise value:
4.7B
EV / Invested capital:
6.38x
Price / LTM sales:
7.23x
EV / EBIT:
--
EV / Revenue:
7.57x
PEG ratio (5yr expected):
-0.57x
EV / Free cash flow:
-4,429.58x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$429.2M
Return On Assets:
-10.7%
Net Income Margin (TTM):
-15.9%
Return On Equity:
-112.03%
Return On Invested Capital:
-13.41%
Operating Margin:
-20.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $430M | $513.2M | $618.6M | $131.9M | $158.7M | |
| Gross Profit | $295.6M | $343.6M | $429.2M | $87.5M | $109.2M | |
| Operating Income | -$104.7M | -$112.7M | -$109.3M | -$38.1M | -$32.6M | |
| EBITDA | -$86.4M | -$100.1M | -$58.7M | -$36.4M | -$21M | |
| Diluted EPS | -$3.47 | -$4.23 | -$3.14 | -$1.47 | -$0.97 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $336.1M | $286.4M | $253.9M | $687.5M | $636M | |
| Total Assets | $478.5M | $428.7M | $421.7M | $909.8M | $926.1M | |
| Current Liabilities | $59.4M | $61.8M | $81.9M | $96.8M | $111.3M | |
| Total Liabilities | $168.9M | $183.9M | $199.9M | $819.5M | $839.4M | |
| Total Equity | $309.6M | $244.8M | $221.8M | $90.3M | $86.7M | |
| Total Debt | $30.1M | $34.9M | $34.9M | $644.1M | $647.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$14.9M | -$71.4M | $47.5M | -$52M | -$7.9M | |
| Cash From Investing | -$40.1M | $35M | -$201.1M | $40M | -$38.1M | |
| Cash From Financing | $13M | $512.6M | $8.5M | $504.6M | $1.7M | |
| Free Cash Flow | -$47.6M | -$113.2M | -$1.1M | -$61.8M | -$17.3M | |
IRTC
Sector
Market Cap
$4.6B
$34.8M
Price % of 52-Week High
98.92%
44.2%
Dividend Yield
0%
0%
Shareholder Yield
-3.67%
-0.6%
1-Year Price Total Return
62.07%
-41.1%
Beta (5-Year)
1.343
0.659
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$141.31
200-day SMA
Buy
Level
$92.40
Bollinger Bands (100)
Buy
Level
95.73 - 123.93
Chaikin Money Flow
Buy
Level
31.1M
20-day SMA
Buy
Level
$132.49
Relative Strength Index (RSI14)
Buy
Level
80.08
ADX Line
Buy
Level
46.61
Williams %R
Sell
Level
-12.5402
50-day SMA
Buy
Level
$114.80
MACD (12, 26)
Buy
Level
8.80
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
17.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8505)
Sell
CA Score
(Annual)
Level (-2.0675)
Buy
Beneish M-Score
(Annual)
Level (-3.4863)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.9398)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Stock Forecast FAQ
In the current month, IRTC has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The IRTC average analyst price target in the past 3 months is $140.42.
-
Where Will iRhythm Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that iRhythm Technologies share price will drop to $140.42 per share over the next 12 months.
-
What Do Analysts Say About iRhythm Technologies?
Analysts are divided on their view about iRhythm Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iRhythm Technologies is a Sell and believe this share price will rise from its current level to $127.00.
-
What Is iRhythm Technologies's Price Target?
The price target for iRhythm Technologies over the next 1-year time period is forecast to be $140.42 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is IRTC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for iRhythm Technologies is a Buy. 9 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IRTC?
You can purchase shares of iRhythm Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iRhythm Technologies shares.
-
What Is The iRhythm Technologies Share Price Today?
iRhythm Technologies was last trading at $142.93 per share. This represents the most recent stock quote for iRhythm Technologies. Yesterday, iRhythm Technologies closed at $142.69 per share.
-
How To Buy iRhythm Technologies Stock Online?
In order to purchase iRhythm Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Cognizant Stock Be In 5 Years?
Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…
NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
33
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
60
MRUS alert for May 24
Merus NV [MRUS] is up 32.55% over the past day.
Buy
57
RGC alert for May 24
Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.
Buy
90
OKLO alert for May 24
Oklo [OKLO] is up 23.11% over the past day.
